The results revealed the significant roles of COX6B1, ACSL1, NDUFA2, CYP1B1, and SLC11A1 in GBM, with the protein expression levels consistent with bioinformatic data and alterations resulting in changes in cell proliferation. This evidence concerns the gene SLC11A1 and glioblastoma.